View this story on The Korea Herald RELATED CONTENT RELATED TOPICS Topic Health Science
Compounds with genuine therapeutic potential attract investment, progress through trials, and eventually reach the market
Individuals with ARTHS present with developmental delay, cognitive impairment (100% penetrance), delay or absence of speech (100%), facial dysmorphism (85%), feeding difficulties (78%), and neonatal hypotonia (76%) in a study of 76 individuals with KAT6A mutations (Kennedy et al, 2019)
However, their cytotoxicity limited their application in nanoparticle design
Note t Dc s: Nhiu ngi dng nng cao nhng thay i chm do hot cht b hao ht ng k ti h tiu ha v gan trc khi vo i tun hon
Cao Z, Bell JB, Mohanty JG, Nagababu E, Rifkind JM